“There has been a massive burst of excitement, and it’s warranted, but not all companies are created equal, and because they carry a cannabis title, one should not immediately think they’re a good company,” venture capitalist Ed McDermott toldMcDermott predicts that there could be as many as 20 cannabis-related companies listed on the LSE by the end of the year.
Despite the good news for investors, cannabis patients and advocates continue to petition the U.K. government to improve access to medical cannabis. More than 40 children in the U.K. with severe forms of epilepsy are at risk of losing access to their medicine due to Brexit restrictions,British prescriptions are no longer recognized in the European Union and with many families travelling to the Netherlands to get their cannabis prescriptions filled — and Dutch law requiring a valid prescription to export cannabis products — those families are still searching for alternatives.
“I am facing the fact that my son might go into refractory epileptic seizures again, which can kill people,” Hannah Deacon, the mother of Alfie Dingley,